Cutaneous manifestations and consequences of smoking

Journal of the American Academy of Dermatology

Volumn 34, Issue 5 I, 1996, Pages A32-732

  Smith, Jeffrey B ^a,b   Fenske, Neil A ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMANS; MOUTH NEOPLASMS; PSORIASIS; SKIN AGING; SKIN DISEASES; SKIN NEOPLASMS; SMOKING; WOUND HEALING;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; CIGARETTE SMOKING; DIABETES MELLITUS; ENTERITIS; HUMAN; LIP CANCER; MELANOMA; MOUTH CANCER; MOUTH LESION; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; PUSTULOSIS; REVIEW; SKIN CANCER; SKIN MANIFESTATION; SKIN METASTASIS; SQUAMOUS CELL CARCINOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; WOUND HEALING;

EID: 85087248130     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(96)90002-x     Document Type: Article

References (311)

1. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993;270:2207-12.
2. Centers for Disease Control and Prevention. Cigarette smoking: attributable mortality and years of potential life lost - United States, 1990. MMWR 1993;42:645-9.
3. Peto R, Lopez AD, Boreham J, et al. Mortality from tobacco in developed countries: indirect estimation from national statistics. Lancet 1992;339:1268-78.
4. Mosley LH, Finseth F. Cigarette smoking: impairment of digital blood flow and wound healing in the hand. Hand 1977;9:97-101.
5. Mosley LH, Finseth F, Goody M. Nicotine and its effects on wound healing. Plast Reconstr Surg 1978;61:570-5.
6. Lawrence WT, Murphy RC, Robson MC, et al. The detrimental effect of cigarette smoking on flap survival: an experimental study in the rat. Br J Plast Surg 1984;37: 216-9.
7. Craig S, Rees TD. The effects of smoking on experimental skin flaps in hamsters. Plast Reconstr Surg 1985;75: 842-6.
8. Nolan J, Jenkins RA, Kurihara K, et al. The acute effects of cigarette smoke exposure on experimental skin flaps. Plast Reconstr Surg 1985;75:544-9.
9. Rees TD. Discussion following Nolan et al. Plast Reconstr Surg 1985;75:550-1.
10. Harris GD, Finseth F, Buncke HJ. The hazard of cigarette smoking following digital replantation. J Microsurg 1980; 1:403-4.
11. Wilson GR, Jones BM. The damaging effect of smoking on digital revascularization: two further case reports. Br J Plast Surg 1984;37:613-4.
12. Siana JE, Rex S, Gottrup F. The effect of cigarette smoking on wound healing. Scand J Plast Reconstr Surg 1989;23:207-9.
13. Rees TD, Liverett DM, Guy CL. The effect of cigarette smoking on skin-flap survival in the face lift patient. Plast Reconstr Surg 1984;73:911-5.
14. Riefkohl R, Wolfe JA, Cox EB, et al. Association between cutaneous occlusive vascular disease, cigarette smoking, and skin slough after rhytidectomy. Plast Reconstr Surg 1986;77:592-5.
15. Webster RC, Kazada G, Hamdan US, et al. Cigarette smoking and face lift: conservative versus wide undermining. Plast Reconstr Surg 1986;77:596-602.
16. Dardour JC, Pugash E, Aziza R. The one-stage preauricular flap for male pattern baldness: long-term results and risk factors. Plast Reconstr Surg 1988;81:907-12.
17. Goldminz D, Bennet RG. Cigarette smoking and flap and full-thickness graft necrosis. Arch Dermatol 1991;127: 1012-5.
18. Bruce JW, Miller JR, Hooker DR. The effect of smoking on the blood pressures and on the volume of the hand. Am J Physiol 1909;24:104-16.
19. Maddock WG, Coller FA. Peripheral vasoconstriction by tobacco demonstrated by skin temperature changes. Proc Soc Exp Biol Med 1932;29:487-8.
20. Maddock WG, Malcolm RL, Coller FA. Thromboangiitis obliterans and tobacco: the influence of sex, race and skin sensitivity to tobacco on cardiovascular responses to smoking. Am Heart J 1936;12:46-52.
21. Barker NW. Vasoconstrictor effects of tobacco smoking. Proc Staff Meet Mayo Clin 1933;8:284-7.
22. Wright IS. Clinical value of human capillary studies in fever, mental deficiency, nephritis, vascular diseases, clubbed fingers, arthritis, tobacco smoking and argyria. JAMA 1933;101:429-42.
23. Wright IS, Moffat D. The effects of tobacco on the peripheral vascular system. JAMA 1934;103:318-23.
24. Weatherby JH. Skin temperature changes caused by smoking and other sympathomimetic stimuli. Am Heart J 1942;24:17-30.
25. Evans WF, Stewart HJ. Effect of smoking cigarettes on the peripheral blood flow. Am Heart J 1943;26:78-91.
26. Roth GM, McDonald JB, Shead C. The effect of smoking cigarettes. JAMA 1944;125:761-7.
27. Lampson RS. A quantitative study of the vasoconstriction induced by smoking. JAMA 1935;104:1963-6.
28. Acevedo A, Schnell A. Effect of cigarette smoking on the finger circulation in normal and diabetic subjects. Basic Res Cardiol 1975;70:350-3.
29. Allison RD, Roth GM. Central and peripheral vascular effects during tobacco smoking. Arch Environ Health 1969;19:189-98.
30. Asano M, Branemark PI. Cardiovascular and microvascular responses to smoking in man. Adv Microcirc 1970; 3:125-58.
31. Eckstein JW, Wood JE, Wilkins RW. Comparative vasoconstrictor effects of inhaling tobacco smoke in warm and cool environments and before and after abstinence from tobacco. Am Heart J 1957;35:455-62.
32. Jonderko G, Podkowka J, Dabrowski Z, et al. Effect of smoking on cutaneous blood supply as determined by the measurement of heat conductivity coefficient. Polish Med J 1966;5:937-43.
33. Redisch W, Messina EJ, Terry EN, et al. Evaluation of vascular responses to tobacco smoking. Angiology 1968; 19:232-7.
34. Richardson D. Effects of tobacco smoke inhalation on capillary blood flow in human skin. Arch Environ Health 1987;42:19-25.
35. Waeber B, Schauer MD, Nussberger J, et al. Skin blood flow reduction induced by cigarette smoking: role of vasopressin. Am J Physiol 1984;247:H895-H901.
36. Reus WF, Robson MC, Zachary L, et al. Acute effects of tobacco smoking on blood flow in the cutaneous microcirculation. Br J Plast Surg 1984;37:213-5.
37. Adrichem LN, Hovius SE, Strik R, et al. Acute effects of cigarette smoking on microcirculation of the thumb. Br J Plast Surg 1992;45:9-11.
38. Sarin CL, Austin JC, Nickel WO. Effects of smoking on digital blood flow velocity. JAMA 1974;229:1327-8.
39. Saumet JL, Leftheriotis G, Dittmar A, et al. Relationship between pulse amplitude and thermal exchange in the finger: the effect of smoking. Clin Physiol 1986;6:139-46.
40. Goodfield MJ, Hume A, Powell NR. The acute effects of cigarette smoking on cutaneous blood flow in smoking and non-smoking subjects with and without Raynaud's phenomenon. Br J Rheumatol 1990;29:89-91.
41. Rottenstein H, Pierce G, Russ E, et al. The influence of nicotine on the blood flow of resting skeletal muscles and of digits in normal subjects. Ann N Y Acad Sci 1960; 90:102-13.
42. Ludbrook J, Vincent AH, Walsh JA. The effects of sham smoking and tobacco smoking on hand blood flow. Aust J Exp Biol Med Sci 1974;52:285-90.
43. Koch A, Hoffman K, Steck W, et al. Acute cardiovascular reaction after cigarette smoking. Atherosclerosis 1980;35:67-75.
44. Shepherd JT. Effect of cigarette smoking on blood flow through the hand. Br Med J 1951;2:1007-10.
45. Silverstein P. Smoking and wound healing. Am J Med 1992;93(suppl):S22-4.
46. Beardwell CG. Radioimmunoassay of arginine vasopressin in human plasma. J Clin Endocrinol Metab 1971; 33:254-60.
47. Burn JH, Truelove LH, Burn I. The antidiuretic action of nicotine and of smoking. Br Med J 1945;1:403-6.
48. Husain MK, Fernando N, Shapiro M, et al. Radioimmunoassay of arginine vasopressin in human plasma. J Clin Endocrinol Metab 1973;37:616-25.
49. Husain MK, Frantz AG, Ciarochi F, et al. Nicotine stimulated release of neurophysin and vasopressin in humans. J Clin Endocrinol Metab 1975;41:1113-7.
50. Rowe JW, Kilgore A, Robertson GL. Evidence in man that cigarette smoking induces vasopressin release via an airway-specific mechanism. J Clin Endocrinol Metab 1980;51:170-2.
51. Armitage AK. Effects of nicotine and tobacco smoke on blood pressure and release of catecholamines from the adrenal gland. Br J Pharmacol 1965;25:515-26.
52. Kirpekar SM, Garcia AG, Prat JC. Action of nicotine on sympathetic nerve terminals. J Pharmacol Exp Ther 1980; 213:133-8.
53. Cryer PE, Haymond MW, Santiago JV, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-7.
54. Westfall TC, Watts DT. Catecholamine excretion in smokers and non-smokers. J Appl Physiol 1964;19: 40-2.
55. Goodman LS, Gillman A, eds. Pharmacologic basis of therapeutics. New York: MacMillan, 1985:555.
56. Lefkowitz RJ. Smoking, catecholamines and the heart. N Engl J Med 1976;295:615-6.
57. Gebber GL. Neurogenic basis for the rise in blood pressure evoked by nicotine in the cat. J Pharmacol Exp Ther 1968;166:255-63.
58. Peacock EE, Van Winkle W. Wound repair. Philadelphia: WB Saunders, 1976:46.
59. Jensen JA, Goodson WH, Hopf HW, et al. Cigarette smoking decreases tissue oxygen. Arch Surg 1991; 126:1131-4.
60. Aronow WS. Smoking, carbon monoxide and coronary heart disease. Circulation 1973;48:1169-72.
61. Holbrook JH. Tobacco. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Principles of internal medicine. New York: McGraw-Hill, 1988:855-9.
62. Astrup P, Kjeldsen K. Carbon monoxide, smoking and atherosclerosis. Med Clin North Am 1974;58:323-50.
63. Hawkins RI. Smoking, platelets, and thrombosis. Nature 1972;236:450-2.
64. Levine PH. An acute effect of cigarette smoking on platelet function: a possible link between smoking and arterial thrombosis. Circulation 1973;48:619-23.
65. Davis JW, Davis RF. Acute effect of tobacco cigarette smoking on the platelet aggregate ratio. Am J Med Sci 1979;278:139-43.
66. Davis JW, Shelton L, Eigenberg DA, et al. Effects of tobacco and non tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 1985;37:529-33.
67. Renaud S, Blache D, Dumont E, et al. Platelet function after cigarette smoking in relation to nicotine and carbon monoxide. Clin Pharmacol Ther 1984;36:389-95.
68. Ambrus JL, Mink IB. Effect of cigarette smoking on blood coagulation. Clin Pharmacol Ther 1964;5:428-31.
69. Birnstingl MA, Brinson K, Chakrabarti BK. The effect of short term exposure to carbon monoxide on platelets' stickiness. Br J Surg 1971;58:837-9.
70. Nadler JL, Velasco JS, Horton R. Cigarette smoking inhibits prostacyclin formation. Lancet 1983;1:1248-50.
71. Mikhailidis DP, Barradas MA, Jeremy JY, et al. Cigarette smoking inhibits prostacyclin formation. Lancet 1983;2:627-8.
72. Belch JJ, McArdle BM, Burns P, et al. The effects of acute smoking on platelet behavior, fibrinolysis and haemorheology in habitual smokers. Thromb Haemost 1984;51:6-8.
73. Dintenfass L. Elevation of blood viscosity, aggregation of red cells, haemocrit values, and fibrinogen levels in cigarette smokers. Med J Aust 1975;1:617-20.
74. Coates F, Richardson DR. Effects of long term tobacco smoke exposure on whole blood viscosity in the rat. Arch Environ Health 1978;33:220-2.
75. Goodson WH, Hunt TK. Wound healing in well controlled diabetic men. Surg Forum 1984;35:614-6.
76. Hunt TK, Pai MP. Effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 1972;135:561-7.
77. Benowitz NL, Jacob P, Jones RT, et al. Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 1982;221:368-72.
78. Gershon-Cohen J, Borden AGB, Hermel MB. Thermography of extremities after smoking. Br J Radiol 1969;42: 189-91.
79. Solly S. Clinical lectures on paralysis. Lancet 1856; 2:641-3.
80. Ippen M, Ippen H. Approaches to a prophylaxis of skin aging. J Soc Cosmet Chem 1965;16:305-8.
81. Daniell HW. Smoker's wrinkles. Ann Intern Med 1971; 75:873-80.
82. Allen HB, Johnson BL, Diamond SM. Smoker's wrinkles? JAMA 1973;225:1067-9.
83. Weiss W. Smoker's wrinkles. JAMA 1973;226:788.
84. Boston DW. Smoker's wrinkles. JAMA 1973;226:788.
85. Daniell HW. Smoker's wrinkles. JAMA 1973;226:788-9.
86. Model D. Smoker's face: An underrated clinical sign? Br Med J 1985;291:1760-2.
87. Model D. Smokers' faces: Who are the smokers? Br Med J 1985;291:1755.
88. Soffer A. Smoker's faces: Who are the smokers? Chest 1986;89:622.
89. Kadunce DP, Burr R, Gress R, et al. Cigarette smoking: risk factor for premature facial wrinkling. Ann Intern Med 1991;114:840-4.
90. Ernster VL, Grady D, Miike R, et al. Facial wrinkling in men and women, by smoking status. Am J Public Health 1995;85:78-82.
91. Kottke TE. Smoking and wrinkles: Does it matter? Ann Intern Med 1991;114:908-9.
92. Davis BE, Koh HK. Faces going up in smoke: a dermatologic opportunity for cancer prevention. Arch Dermatol 1992;128:1106-7.
93. Wolf R, Tur E, Wolf D, et al. The effect of smoking on skin moisture and on surface lipids. Int J Cosmet Sci 1992;14:83-8.
94. Frances C. Smoking and the skin. Int J Dermatol 1992; 31:779-80.
95. Frances C, Boisnic S, Hartmann DJ, et al. Changes in the elastic tissue of non-sun-exposed skin of cigarette smokers. Br J Dermatol 1991;125:43-7.
96. Weitz JI, Crowley KA, Landman SL, et al. Increased neutrophil elastase activity in cigarette smokers. Ann Intern Med 1987;107:680-2.
97. Laurent P, Janoff A, Kagan HM. Cigarette smoke blocks cross-linking of elastin in vitro. Ann Rev Respir Dis 1983;127:189-94.
98. Joffe I. Cigarette smoking and facial wrinkling. Ann Intern Med 1991;115:659.
99. Reitamo S, Erkko P, Remitz A, et al. Cyclosporin in the treatment of palmoplantar pustulosis. Arch Dermatol 1993;129:1273-9.
100. O'Doherty CJ, Macintyre C. Palmplantar pustulosis and smoking. Br Med J 1985;291:861-4.
101. O'Doherty CJ. The prevalence of cigarette smoking in patients with palmo-plantar pustulosis. Scott Med J 1984;29:54.
102. Cox NH, Ray S. Neutrophil leukocyte morphology, cigarette smoking, and palmoplantar pustulosis. Int J Dermatol 1987;26:445-7.
103. Baughman RD. Psoriasis and cigarettes. Another nail in the coffin [Editorial]. Arch Dermatol 1993;129:1329-30.
104. Corre F, Lellouch J, Schwarte D. Smoking and leukocyte counts: results of an epidemiological survey. Lancet 1971;2:632-4.
105. Hellman N, Rubenstein LS. The effects of age, sex, and smoking on erythrocytes and leukocytes. Am J Clin Pathol 1975;63:35-44.
106. Winkel P, Statland BE. The acute effect of cigarette smoking on the concentrations of blood leukocyte types in healthy young women. Am J Clin Pathol 1981;75:781-5.
107. Yeung MC, Buncio AD. Leukocyte count, smoking, and lung function. Am J Med 1984;76:31-7.
108. Ludwig PW, Hoidal JR. Alterations in leukocyte oxidative metabolism in cigarette smokers. Am Rev Respir Dis 1982;126:977-80.
109. Chang WC, Fukada S, Tai HH. Cigarette smoking stimulates lipoxygenase but not cyclooxygenase pathway in platelets. Biochem Biophys Res Commun 1983;115:499-505.
110. Sonnex TS, Carrington P, Norris P, et al. Polymorphonuclear leukocyte random migration and chemotaxis in psoriatic and healthy adult smokers and non-smokers. Br J Dermatol 1988;119:653-9.
111. Kavli G, Forde OH, Arnesen E, et al. Psoriasis: familial predisposition and environmental factors. Br Med J 1985;291:999-1000.
112. Braathen LR, Botten G, Bjerkedal T. Psoriatics in Norway. Acta Derm Venereol Suppl (Stockh) 1989;142:9-12.
113. Poikolainen K, Reunala T, Karvonen J, et al. Alcohol intake: A risk factor for psoriasis in young and middle aged men? Br Med J 1990;300:780-3.
114. Bell LM, Sedlack R, Beard M, et al. Incidence of psoriasis in Rochester, Minn, 1980-1983. Arch Dermatol 1991;127:1184-7.
115. Naldi L, Parazzini F, Brevi A, et al. Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 1992;127:212-7.
116. Mills CM, Srivastava ED, Harvey IM, et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992;127:18-21.
117. Poikolaninen K, Reunala T, Karvonen J. Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 1994;130:473-7.
118. Shaw HM, Milton GW, McCarthy WH, et al. Effect of smoking on the recurrence of malignant melanoma. Med J Aust 1979;1:208-9.
119. Shaw HM, Milton GW. Smoking and the development of metastases from malignant melanoma. Int J Cancer 1981; 28:153-6.
120. White LP. Studies on melanoma: sex and survival in human melanoma. N Engl J Med 1959;260:789-97.
121. Cochran AJ. Malignant melanoma: a review of 10 years experience in Glasgow, Scotland. Cancer 1969;23:1190-9.
122. Shaw HM, Milton GW, Farago G, et al. Endocrine influences on survival from malignant melanoma. Cancer 1978;42:669-77.
123. Rampen FHJ. Sex differences in survival from cutaneous melanoma. Int J Dermatol 1984;23:444-52.
124. Shaw HM, McGovern VJ, Milton GW, et al. Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer 1980;45:1604-8.
125. Rigel DS, Friedman RJ, Levine J, et al. Cigarette smoking and malignant melanoma. J Dermatol Surg Oncol 1981;7:889-91.
126. Koh HK, Sober AJ, Day CL, et al. Cigarette smoking and malignant melanoma. Cancer 1984;53:2570-3.
127. Dintenfass L. Effect of smoking on the recurrence of malignant melanoma. Med J Aust 1979;1:620.
128. Holt PG, Keast D. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol Rev 1977;41:205-16.
129. Ferson M, Edwards A, Lind A, et al. Low natural killer-cell activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979;23:603-9.
130. Thomas WR, Holt PG, Keast D. Recovery of immune system after cigarette smoking. Nature 1974;248:358-9.
131. Thomas WR, Holt PG, Keast D. Effects of cigarette smoking on primary and secondary humoral responses of mice. Nature 1973;243:240-1.
132. Chalmer J, Holt PG, Keast D. Cell mediated immune responses to transplanted tumours in mice chronically ex-posed to cigarette smoke. J Natl Cancer Inst 1975;55:1129-34.
133. Finlea JF, Hasselblad V, Riggan WB, et al. Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization. Am Rev Respir Dis 1971;104:367-76.
134. Nymand G. Maternal smoking and immunity. Lancet 1974;2:1379-80.
135. Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Med J Aust 1983;2:425-9.
136. Chretien PB. The effects of smoking on immunocompetence. Laryngoscope 1978;88(suppl 8):11-3.
137. Ghadially FN, Barton BW, Kerridge DF. The etiology of keratoacanthoma. Cancer 1963;16:603-11.
138. Aubry F, MacGibbon B. Risk factors of squamous cell carcinoma of the skin. Cancer 1985;55:907-11.
139. Karagas MR, Stukel TA, Greenburg R, et al. Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 1992;267:3305-10.
140. Grodstein F, Speizer FE, Hunter DJ. A prospective study of incident squamous cell carcinoma of the skin in the Nurses Health Study. J Natl Cancer Inst 1995;87:1061-6.
141. Hellberg D, Valentin J, Eklund T, et al. Penile cancer: Is there an epidemiological role for smoking and sexual behavior? Br Med J 1987;295:1306-8.
142. Maden C, Sherman KJ, Beckmann AM. History of circumcision, medical conditions, and sexual activity and risk of penile cancer. J Natl Cancer Inst 1993;85:19-24.
143. Daniell HW. Re: causes of anal cancer. JAMA 1985;254: 358.
144. Daling JR, Weiss NS, Hislop G, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987;317:973-7.
145. Holmes F, Borek D, Owen-Kummer M, et al. Anal cancer in women. Gastroenterology 1988;95:107-11.
146. Newcomb PA, Weiss NS, Daling JR. Incidence of vulvar carcinoma in relation to menstrual, reproductive, and medical factors. J Natl Cancer Inst 1984;73:391-6.
147. Mabuchi K, Bross DS, Kessler II. Epidemiology of cancer of the vulva. Cancer 1985;55:1843-8.
148. Brinton LA, Nasca PC, Mallin K, et al. Case-control study of cancer of the vulva. Obstet Gynecol 1990;75:859-66.
149. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992;135:180-9.
150. Hoover R, Fraumeni JF. Risk of cancer in renal transplant recipients. Lancet 1973;2:55-7.
151. Hoxtell EO, Mandell JS, Murray SS, et al. Incidence of skin carcinoma after renal transplantation. Arch Dermatol 1977;113:436-8.
152. Mahoney JF, Sheil AGR, Etheredge SB, et al. Delayed complications of renal transplantation and their prevention. Med J Aust 1982;2:426-9.
153. Kinlen LJ, Sheil AGR, Peto J, et al. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979;2:1461-6.
154. Wynder ED, Hoffman D. Experimental tobacco carcinogenesis. Adv Cancer Res 1964;8:249-53.
155. Carmella SG, Kagan SS, Kagan M, et al. Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res 1990;50:5438-45.
156. Bartsch H, Caporaso N, Coda M, et al. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 1990;82:1826-31.
157. Hellburg D, Nilsson S, Haley NJ, et al. Smoking and cervical intraepithelial neoplasia: nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers. Am J Obstet Gynecol 1988;158:910-3.
158. Petrakis NL, Gruenke LD, Beelen TC, et al. Nicotine in breast fluid of nonlactating women. Science 1978;199: 303-4.
159. Decker J, Goldstein JC. Risk factors in head and neck cancer. N Engl J Med 1982;306:1151-5.
160. Smart CR, Lyon JL, Skolnick M, et al. Cancer of the head and neck in Utah. Am J Surg 1974;128:463-5.
161. Bender JL, Clark ML. Squamous cell carcinoma of the lip: a critical statistical and morphological analysis of 835 cases. Mil Surg 1951;109:379-405.
162. Keller AZ. Cellular types, survival, race, nativity, occupation, habits and associated diseases in the pathogenesis of lip cancer. Am J Epidemiol 1970;91:486-9.
163. Ashley FL, McConnel DV, Machida R, et al. Carcinoma of the lip. Am J Surg 1965;110:549-51.
164. Ratzkowski E, Hochman A, Buchner A, et al. Causes of cancer of the lip: review of 167 cases. Oncologia 1966; 20:129-44.
165. Molnar L, Ronay P, Tapolcsani L. Carcinoma of the lip: analysis of the material of 25 years. Oncology 1974; 29:101-21.
166. Wurman LH, Adams GL, Myerhoff WL. Carcinoma of the lip. Am J Surg 1975;130:470-4.
167. Marshall KA, Edgerton MT. Indications for neck dissection in carcinoma of the lip. Am J Surg 1977;133: 216-7.
168. Martin H, MacComb WS, Blady JV. Cancer of the lip. Ann Surg 1941;114:226-42.
169. Cross JE, Guralnick E, Daland EM. Carcinoma of the lip. Surg Gynecol Obstet 1948;87:153.
170. Jorgensen K, Elbrond O, Andersen AD. Carcinoma of the lip: a series of 869 cases. Acta Radiol 1973;12:177-90.
171. Creely JJ. Carcinoma of the lip. South Med J 1974;67:779-84.
172. Baker SR. Risk factors in multiple carcinomas of the lip. Otolaryngol Head Neck Surg 1980;88:248-51.
173. Widmann BP. Cancer of the lip. Am J Roentgenol 1950; 63:13-24.
174. Spitzer WO, Hill GB, Chambers LW, et al. The occupation of fishing as a risk factor in cancer of the lip. N Engl J Med 1975;293:419-24.
175. Blomqvist G, Hirsch JM, Alberius P. Association between development of lower lip cancer and tobacco habits. J Oral Maxillofac Surg 1991;49:1044-7.
176. Lindqvist C. Risk factors in lip cancer. Am J Epidemiol 1979;109:521-30.
177. King GN, Healy CM, Glover MT, et al. Increased prevalence of dysplastic and malignant lip lesions in renal transplant recipients. N Engl J Med 1995;332:1052-7.
178. Douglass CW, Gammon MD. Reassessing the epidemiology of lip cancer. Oral Surg 1984;57:631-42.
179. Wynder EL, Bross IJ, Feldman RM. A study of the etiologic factors in cancer of the mouth. Cancer 1957;10: 1300-23.
180. Wynder EL, Bross IJ. Aetiological factors in mouth cancer: an approach to its prevention. Br Med J 1957; 1:1137-42.
181. Keller AZ. The epidemiology of lip, oral, and pharyngeal cancers, and the association with selected systemic diseases. Am J Public Health 1963;53:1214-28.
182. Vogler WR, Lloyd JW, Millmore BK. A retrospective study of etiological factors in cancer of the mouth, pharynx and larynx. Cancer 1962;15:246-8.
183. Keller AZ, Terris M. The association of alcohol and tobacco with cancer of the mouth and pharynx. Am J Public Health 1965;55:1578-85.
184. Keller AZ. Cirrhosis of the liver, alcoholism and heavy smoking associated with cancer of the mouth and pharynx. 1967;20:1015-22.
185. Cady B, Catlin D. Epidermoid carcinomas of the gum: a 20-year survey. Cancer 1969;23:551-69.
186. Kolson H, Spiro RH, Rosewit B, et al. Epidermoid carcinoma of the floor of the mouth: analysis of 108 cases. Arch Otolaryngol 1971;93:280-3.
187. Moore C. Cigarette smoking and cancer of the mouth, pharynx, and larynx. A continuing study. JAMA 1971; 218:553-8.
188. Jusawalla DJ, Deshpande VA. Evaluation of cancer risk in tobacco chewers and smokers: an epidemiological assessment. Cancer 1971;28:244-52.
189. Rothman KJ, Keller AZ. The effect of joint exposure to alcohol and tobacco on the risk of cancer of the mouth and pharynx. J Chron Dis 1972;25:711-6.
190. Larato DC. Oral cancer in a male veteran hospital population. J Oral Med 1974;29:29-31.
191. Bross IDJ, Coombs J. Early onset of oral cancer among women who drink and smoke. Oncology 1976;33:136-9.
192. Graham S, Dayal H, Rohrer T, et al. Dentition, diet, tobacco and alcohol in the epidemiology of oral cancer. J Natl Cancer Inst 1977;59:1611-8.
193. Williams RR, Horms JW. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J Natl Cancer Inst 1977;58:525-47.
194. Smith EM. Epidemiology of oral and pharyngeal cancers in the United States: review of recent literature. J Natl Cancer Inst 1979;63:1189-98.
195. Ellwood JM, Pearson JCG, Skippen DH, et al. Alcohol, smoking, social and occupational factors in the etiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer 1984;34:603-12.
196. Brugere J, Quenel P, Leclerc A, et al. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx and mouth. Cancer 1986;57:391-5.
197. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:1282-7.
198. Boyle P, Macfarlane GJ, Maisonneuve P, et al. Epidemiology of mouth cancer in 1989: a review. J R Soc Med 1990;83:724-30.
199. Choi SY, Kahyo H. Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Epidemiol 1991;20:878-85.
200. Franceschi S, Barra S, La Vecchia C, et al. Risk factors for cancer of the tongue and the mouth: a case-control study from northern Italy. Cancer 1992;70:2227-33.
201. Boffetta P, Mashberg A, Winkelman R, et al. Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx. Int J Cancer 1992;52:530-3.
202. Maier H, Dietz A, Gewelke U, et al. Tobacco and alcohol and the risk of head and neck cancer. Clin Invest 1992; 70:320-7.
203. Mashberg A, Boffetta P, Winkelman R, et al. Tobacco smoking, alcohol drinking, and cancer of the oral cavity and oropharynx among U.S. veterans. Cancer 1993;72: 1369-75.
204. Barasch A, Morse DE, Krutchkoff DJ, et al. Smoking, gender, and age as risk factors for site-specific intraoral squamous cell carcinoma: a case-series analysis. Cancer 1994;73:509-13.
205. Plesko I, Macfarlane GJ, Evstifeeva TV, et al. Oral and pharyngeal cancer incidence in Slovakia 1968-1989. Int J Cancer 1994;56:481-6.
206. Llewelyn J, Mitchell R. Smoking, alcohol and oral cancer in southeast Scotland: a 10-year experience. Br J Oral Maxillofac Surg 1994;32:146-52.
207. Winn DM, Blot WJ, Shy CM, et al. Snuff dipping and oral cancer among women in the southern United States. N Engl J Med 1981;304:745-9.
208. Christen AG. The impact of tobacco use and cessation on oral and dental diseases and conditions. Am J Med 1992; 93(suppl):25S-31S.
209. Winn DM. Smokeless tobacco and cancer: the epidemiological evidence. CA Cancer J Clin 1988;38:236-43.
210. Stich HF, Parida BB, Brunnemann KD. Localized formation of micronuclei in the oral mucosa and tobacco-specific nitrosamines in the saliva of "reverse" smokers, khaini-tobacco chewers and gudakhu users. Int J Cancer 1992;50:172-6.
211. Gupta PC, Mehta FS, Pindborg JJ. Mortality among reverse chutta smokers in South India. Br Med J 1984; 289:865-6.
212. Banoczy J, Rigo O. Prevalence study of oral precancerous lesions within a complex screening system in Hungary. Community Dent Oral Epidemiol 1991;19:265-7.
213. Feller L, Altini M, Slabbert H. Pre-malignant lesions of the oral mucosa in a South African sample: a clinico-pathological study. J Dent Assoc South Afr 1991;46:261-5.
214. Pindborg JJ, Chawla TN, Misra RK, et al. Frequency of oral carcinoma, leukoplakia, leukokeratosis, leukoedema, submucous fibrosis and lichen planus in 10,000 Indians in Luchnow, Uttar Pradesh, India: preliminary report. J Dent Res 1965;44:615.
215. Roed-Peteren B. Effect on oral leukoplakia of reducing or ceasing tobacco smoking. Acta Derm Venereol (Stockh) 1982;62:164-7.
216. Dorey JL, Blasberg B, Conklin RJ, et al. Oral leukoplakia: current concepts in diagnosis, management, and malignant potential. Int J Dermatol 1984;23:638-42.
217. Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 1977;5:69-75.
218. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study of 257 patients. Cancer 1984;53:563-8.
219. Waldron CA, Shafer WG. Current concepts in leukoplakia. Int Dent J 1960;10:350-67.
220. Weisberger D. Precancerous lesions. J Am Dent Assoc 1957;54:507-8.
221. Mehta FS, Shroff BC, Gupta PC, et al. Oral leukoplakia in relation to tobacco habits. Oral Surg 1972;34:426-33.
222. Mashberg A, Samit AM. Early oral and oropharyngeal cancer: diagnosis and management. In: Schwartz RA, ed. Skin cancer recognition and management. New York: Springer, 1988:226.
223. Allen CM, Camisa C. Diseases of the mouth and lips. In: Sams WM, Lynch PJ, eds. Principles and practice of dermatology. New York: Churchill-Livingstone, 1990:913-41.
224. Gallagher GT. Disorders of the mucocutaneous integument. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in general medicine. New York: McGraw-Hill, 1993:1355-417.
225. Saietz L. Prevalence of leukokeratosis nicotina palati among 3,819 Danes. Community Dent Oral Epidemiol 1975;3:80-5.
226. Farman AG, Van Wyk CW. Leukokeratosis nicotina glossi: smokers' tongue. Int J Oral Surg 1977;6:340-7.
227. Johnson BD, Engel D. Acute necrotizing ulcerative gingivitis: a review of diagnosis, etiology and treatment. J Periodontol 1986;57:141-50.
228. Pollman L, Dietrich A. Acute necrotizing gingivitis in young men. Dtsch Zahn Z 1979;34:222-4.
229. Shields WD. Acute necrotizing ulcerative gingivitis: a study of some of the contributing factors and their validity in an Army population. J Periodontol 1977;48:346-9.
230. Stevens AW, Cogen RB, Cohen-Cole S, et al. Demographic and clinical data associated with acute necrotizing ulcerative gingivitis in a dental school population. J Clin Periodontol 1984;11:487-93.
231. Arnold HL, Odom RB, James WD, eds. Andrews' Diseases of the skin. Philadelphia: WB Saunders, 1990:931.
232. Axell T, Hedin CA. Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits. Scand Dent Res 1982;90:434-42.
233. Mesa ML, Lambert WC, Schneider LC, et al. Oral warty dyskeratoma. Cutis 1984;33:293-5.
234. Salonen L, Axel T, Helden L. Occurrence of oral mucosal lesions, the influence of tobacco habits and an estimate of treatment time in an adult Swedish population. J Oral Pathol Med 1990;19:170-6.
235. Karvonen J, Poikainen K, Reunala T, et al. Alcohol and smoking: Risk factors for infectious eczematoid dermatitis? Acta Derm Venereol (Stockh) 1992;72:208-10.
236. Morren MA, Przybilla B, Bamelis M, et al. Atopic dermatitis: triggering factors. J AM ACAD DERMATOL 1994;31:467-73.
237. Shelley WB, Shelley ED. Portrait of a practice. Cutis 1995;55:73-80.
238. Mills CM, Srivastava ED, Harvey IM, et al. Cigarette smoking is not a risk factor in atopic dermatitis. Int J Dermatol 1994;33:33-4.
239. Abdullah AN, Keczkes K. Thromboangiitis obliterans (Buerger' s disease) in a woman: a case report and review of the literature. Clin Exp Dermatol 1990;15:46-9.
240. Arnold HL, Odom RB, James WD. Andrews' Diseases of the skin. Philadelphia: WB Saunders, 1990:973.
241. Bundred NJ, Dover MS, Aluwihare N, et al. Smoking and periductal mastitis. Br Med J 1993;307:772-3.
242. Verghese A, Krish G, Howe D, et al. The harlequin nail: a marker for smoking cessation. Chest 1990;97:236-8.
243. Verghese A. Quitter's nail. N Engl J Med 1994;330:974.
244. Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr 1994;7:599-606.
245. Kataja V, Syrjanen S, Yliskoski M, et al. Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol 1993;138:735-45.
246. Burger MP, Hollema H, Gouw AS, et al. Cigarette smoking and human papillomavirus in patients with reported cervical cytological abnormality. BMJ 1993;306:749-52.
247. Brisson J, Roy M, Fortier M, et al. Condyloma and intraepithelial neoplasia of the uterine cervix: a case-control study. Am J Epidemiol 1988;128:337-42.
248. Phillips AN, Smith GD. Smoking and human papillomavirus infection. BMJ 1993;306:1268.
249. Daling JR, Sherman KJ, Weiss NS. Risk factors for condyloma acuminatum in women. Sex Trans M Dis 1986;13:16-8.
250. Sideri M, Parazzini F, Rognoni MT, et al. Risk factors for vulvar lichen sclerosus. Am J Obstet Gynecol 1989;161: 38-42.
251. Mills CM, Finlay AY. Does smoking influence acne? Clin Exp Dermatol 1993;18:100-1.
252. Axell T, Leidholm R. Occurrence of recurrent herpes labialis in an adult Swedish population. Acta Odontol Scand 1990;48:119-23.
253. Fader DJ, Metzman MS. Hazards of smoking during therapy for psoriasis. N Engl J Med 1994;330:1541.
254. Jordan WP. Clinical evaluation of the contact sensitization potential of a transdermal nicotine system (Nicoderm). J Fam Pract 1992;34:709-12.
255. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation: six-month results from two multicenter controlled clinical trials. JAMA 1991;266:3133-8.
256. Orleans CT, Resch N, Noll E, et al. Use of transdermal nicotine in a state-level prescription plan for the elderly. JAMA 1994;271:601-7.
257. Bircher AJ, Howald H, Rufli T. Adverse skin reactions to nicotine in a transdermal therapeutic system. Contact Dermatitis 1991;25:230-6.
258. Goncalo M, Couto J, Goncalo S. Allergic contact dermatitis from nicotiana tabacum. Contact Dermatitis 1990;22: 188-9.
259. Nakamura T. Tobacco dermatitis in Japanese harvesters. Contact Dermatitis 1984;10:310.
260. Rycroft RJG. Tobacco dermatitis. Br J Dermatol 1980; 103:225-9.
261. Rycroft RJG, Smith NP, Stok ET, et al. Investigation of suspected contact sensitivity to tobacco in cigarette and cigar factory employees. Contact Dermatitis 1981;7:32-8.
262. Pecequeiro M. Airborne contact dermatitis to tobacco. Contact Dermatitis 1987;17:50.
263. Dover JS, Johnson RA. Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol 1991;127:1383-91.
264. Ray MC, Gately LE. Dermatologic manifestations of HIV infection and AIDS. Infect Dis Clin North Am 1994;8:583-605.
265. Herman KL, Jacoby RA, Webster G. Pathology of HIV-related skin diseases. Clin Dermatol 1991;9:95-110.
266. Zalla MJ, Su WP, Fransway AF. Dermatologic manifestations of human immunodeficiency virus infection. Mayo Clin Proc 1992;67:1089-108.
267. Cockerell CJ. Cutaneous clues to HIV infection: diagnosis and treatment. Semin Dermatol 1994;13:275-85.
268. Newell GR, Mansell PWA, Wilson MB, et al. Risk factors analysis among men referred for possible acquired immune deficiency syndrome. Prev Med 1985;14: 81-91.
269. Berger LR. Cigarette smoking and the acquired immunodeficiency syndrome. Ann Intern Med 1988;108:638.
270. Royce RA, Winkelstein Jr W. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS 1990;4:327-33.
271. Burns DN, Kramer A, Yellin F, et al. Cigarette smoking: A modifier of human immunodeficiency virus type I infection? J Acquir Immune Defic Syndr 1991;4:76-83.
272. Halsey NA, Coberly JS, Holt E, et al. Sexual behavior, smoking, and HIV-1 infection in Haitian women. JAMA 1992;267:2062-6.
273. Nieman RB, Fleming J, Coker RJ, et al. The effect of cigarette smoking on the development of AIDS in HIV-1 seropositive individuals. AIDS 1993;7:705-10.
274. Perez MI, Kohn SR. Cutaneous manifestations of diabetes mellitus. J AM ACAD DERMATOL 1994;30:519-31.
275. Muller SA. Dermatologic disorders associated with diabetes mellitus. Mayo Clin Proc 1966;41:689-703.
276. Bernstein JE. Cutaneous manifestations of diabetes mellitus. Curr Concepts Skin Dis 1980;1:3-10.
277. Huntley AC. The cutaneous manifestations of diabetes mellitus. J AM ACAD DERMATOL 1982;7:427-55.
278. Sibbald RG, Schachter RK. The skin and diabetes mellitus. Int J Dermatol 1984;23:567-84.
279. Goodfield MJD, Millard LG. The skin in diabetes mellitus. Diabetologica 1988;31:567-75.
280. Huntley AC. Cutaneous manifestations of diabetes mellitus. Dermatol Clin 1989;7:531-46.
281. Meurer M, Szeimies RM. Diabetes mellitus and skin diseases. Curr Probl Dermatol 1991;20:11-23.
282. Jelinek JE. The skin in diabetes. Diabet Med 1993;10:201-13.
283. Huntley AC. Cutaneous manifestations of diabetes mellitus. Diabetes Metab Rev 1993;9:161-76.
284. Rimm EB, Manson JE, Stampfer MJ, et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health 1993;83:211-4.
285. Rimm EB, Chan J, Stampfer MJ, et al. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995;310:555-9.
286. Nelson DE, Kirkendall RS, Lawton RL, et al. Surveillance for smoking: attributable mortality and years of potential life lost, by state - United States, 1990. MMWR 1994; 43:1-8.
287. Bartecchi CE, MacKenzie TD, Schrier RW. The human cost of tobacco use. N Engl J Med 1994;330:907-12.
288. Fielding JE. Smoking: health effects and control. N Engl J Med 1985;313:491-8.
289. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J AM ACAD DERMATOL 1993;29:228-36.
290. Lookingbill DP, Spangler N, Sexton M. Skin involvement as the presenting sign of internal carcinoma. J AM ACAD DERMATOL 1990;22:19-26.
291. Tharakaram S. Metastases to the skin. Int J Dermatol 1988;27:240-2.
292. Rosen T. Cutaneous metastases. Med Clin North Am 1980;64:885-900.
293. Gregory B, Ho VC. Cutaneous manifestations of gastrointestinal disorders. Part II. J AM ACAD DERMATOL 1992;26:371-83.
294. McCallum DI, Kinmont PD. Dermatological manifestations of Crohn's disease. Br J Dermatol 1968;80:1-8.
295. Basler RSW, Dubin HV. Ulcerative colitis and the skin. Arch Dermatol 1976;112:531-4.
296. Paller AS. Cutaneous changes associated with inflammatory bowel disease. Pediatr Dermatol 1986;3:439-45.
297. Vreeken J, Tijtgat GN, Wackers FJ, et al. Inflammatory bowel disease: cutaneous manifestations. Compr Ther 1978;4:20-4.
298. Loeffel ED, Koya D. Cutaneous manifestations of gastrointestinal disease. Cutis 1978;21:852-61.
299. Wakefield AJ, Sawyerr AM, Dhillon AP, et al. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991;36:1147-50.
300. Katschinski B, Fingerle D, Scherbaum B, et al. Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci 1993;38:1596-600.
301. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-8.
302. Samuelsson SM, Ekbom A, Zack M, et al. Risk factors for extensive ulcerative colitis and ulcerative proctitis: a population based case-control study. Gut 1991;32:1526-30.
303. Srivasta ED, Newcombe RG, Rhodes J, et al. Smoking and ulcerative colitis: a community study. Int J Colorectal Dis 1993;8:71-4.
304. Silverstein MD, Lashner BA, Hanauer SB. Cigarette smoking and ulcerative colitis: a case-control study. Mayo Clin Proc 1994;69:425-9.
305. Provost TT, Zone JJ, Synkowski D, et al. Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions: correlation with clinical and serological abnormalities. J Invest Dermatol 1980;75:495-9.
306. Witkowski JA. Cutaneous manifestations of systemic diseases: collagen vascular disease and vasculitis. Clin Dermatol 1983;1:88-101.
307. Weinstein C, Miller MH, Axten R, et al. Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus. Aus N Z J Med 1987;17:501-6.
308. Watson R. Cutaneous lesions in systemic lupus erythematosus. Med Clin North Am 1989;73:1091-111.
309. McCauliffe DP, Sontheimer RD. Dermatologic manifestations of rheumatic disorders. Prim Care 1993;20:925-41.
310. Nagata C, Fujita S, Iwata H, et al. Systemic lupus erythematosus: a case-control epidemiologic study in Japan. Int J Dermatol 1995;34:333-7.
311. Benoni C, Nilsson A, Nived O. Smoking and inflammatory bowel disease. Comparison with systemic lupus erythematosus: a case-control study. Scand J Gastroenterol 1990;25:751-5.